Binswanger Ingrid A, Joseph Nicole, Hanratty Rebecca, Gardner Edward M, Durfee Josh, Narwaney Komal J, Breslin Kristin, Mueller Shane R, Glanz Jason M
Institute for Health Research, Kaiser Permanente Colorado, Denver, CO.
Colorado Permanente Medical Group, Denver, CO.
Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 2;2(4):309-316. doi: 10.1016/j.mayocpiqo.2018.09.005. eCollection 2018 Dec.
To develop and evaluate a novel Opioid Safety Clinic (OSC) initiative to enhance adherence to guidelines on the assessment and monitoring of patients prescribed chronic opioid therapy (COT).
The OSC was developed at an urban Federally Qualified Health Center to provide guideline-concordant care for COT, standardize workflows, and efficiently use clinic staff. We evaluated the OSC using a matched cohort study. Five hundred thirty-nine patients participated in the clinic between July 1, 2014, and March 31, 2016. Of these, 472 clinic participants were matched to 472 nonparticipants by sex and age on the date of the OSC visit. The OSC was evaluated by its completion rates of standardized pain assessments, urine toxicology, and naloxone dispensings. We conducted logistic regression comparing OSC participants to OSC nonparticipants.
A total of 539 patients attended an OSC visit, representing approximately 53% of patients in the chronic opioid registry. The OSC participants were more likely than nonparticipants to have completed a pain assessment (adjusted odds ratio [aOR], 169.8; 95% CI, 98.3-293.5), completed a urine toxicology (aOR, 46.1; 95% CI, 30.4-69.9), or had naloxone dispensed (aOR, 2.8; 95% CI, 1.9-4.3) over 12 months of follow-up.
The OSC model improved adherence to guideline-concordant COT in primary care. Future research is needed to assess the impact of these interventions on pain, quality of life, and adverse events from opioid analgesics.
制定并评估一项新型阿片类药物安全诊所(OSC)倡议,以提高对慢性阿片类药物治疗(COT)患者评估和监测指南的依从性。
OSC在一家城市联邦合格健康中心设立,为COT提供符合指南的护理,规范工作流程,并有效利用诊所工作人员。我们采用匹配队列研究对OSC进行评估。2014年7月1日至2016年3月31日期间,539名患者参与了该诊所。其中,472名诊所参与者在OSC就诊日期按性别和年龄与472名未参与者进行匹配。通过标准化疼痛评估、尿液毒理学和纳洛酮配给的完成率对OSC进行评估。我们进行了逻辑回归,比较OSC参与者和非参与者。
共有539名患者参加了OSC就诊,约占慢性阿片类药物登记患者的53%。在12个月的随访中,OSC参与者比非参与者更有可能完成疼痛评估(调整优势比[aOR],169.8;95%可信区间[CI],98.3 - 293.5)、完成尿液毒理学检查(aOR,46.1;95% CI,30.4 - 69.9)或获得纳洛酮配给(aOR,2.8;95% CI,1.9 - 4.3)。
OSC模式提高了初级保健中对符合指南的COT的依从性。需要进一步研究来评估这些干预措施对疼痛、生活质量和阿片类镇痛药不良事件的影响。